292 related articles for article (PubMed ID: 37180116)
1. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy.
Zheng X; Wan J; Tan G
Front Immunol; 2023; 14():1151185. PubMed ID: 37180116
[TBL] [Abstract][Full Text] [Related]
2. Targeting the NLRP3 inflammasome in diabetic retinopathy: From pathogenesis to therapeutic strategies.
Yang Y; Jiang G; Huang R; Liu Y; Chang X; Fu S
Biochem Pharmacol; 2023 Jun; 212():115569. PubMed ID: 37100255
[TBL] [Abstract][Full Text] [Related]
3. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
Chen W; Zhao M; Zhao S; Lu Q; Ni L; Zou C; Lu L; Xu X; Guan H; Zheng Z; Qiu Q
Inflamm Res; 2017 Feb; 66(2):157-166. PubMed ID: 27785530
[TBL] [Abstract][Full Text] [Related]
4. Characterization of NLRP3 Inflammasome Activation in the Onset of Diabetic Retinopathy.
Kuo CY; Maran JJ; Jamieson EG; Rupenthal ID; Murphy R; Mugisho OO
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430950
[TBL] [Abstract][Full Text] [Related]
5. Role of pyroptosis in diabetic retinopathy and its therapeutic implications.
Al Mamun A; Mimi AA; Zaeem M; Wu Y; Monalisa I; Akter A; Munir F; Xiao J
Eur J Pharmacol; 2021 Aug; 904():174166. PubMed ID: 33979651
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of the NLRP3 Inflammasome in Diabetic Retinopathy and Potential Therapeutic Targets.
Raman KS; Matsubara JA
Ocul Immunol Inflamm; 2022 Feb; 30(2):470-478. PubMed ID: 33026924
[TBL] [Abstract][Full Text] [Related]
7. NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy.
Zhang L; Ai C; Bai M; Niu J; Zhang Z
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142531
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis.
Gaul S; Leszczynska A; Alegre F; Kaufmann B; Johnson CD; Adams LA; Wree A; Damm G; Seehofer D; Calvente CJ; Povero D; Kisseleva T; Eguchi A; McGeough MD; Hoffman HM; Pelegrin P; Laufs U; Feldstein AE
J Hepatol; 2021 Jan; 74(1):156-167. PubMed ID: 32763266
[TBL] [Abstract][Full Text] [Related]
9. High Glucose Induces the Loss of Retinal Pericytes Partly via NLRP3-Caspase-1-GSDMD-Mediated Pyroptosis.
Gan J; Huang M; Lan G; Liu L; Xu F
Biomed Res Int; 2020; 2020():4510628. PubMed ID: 32420343
[TBL] [Abstract][Full Text] [Related]
10. Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-κB signaling pathway.
Yin Y; Chen F; Wang W; Wang H; Zhang X
Mol Vis; 2017; 23():242-250. PubMed ID: 28465656
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of TSPO-VDAC complex is correlated with NLRP3 inflammasome activation in diabetic retinopathy.
Guo Y; Sun Z; Wang L; Jiang R; Shu Q; Xu G
Mol Med Rep; 2022 Dec; 26(6):. PubMed ID: 36205135
[TBL] [Abstract][Full Text] [Related]
12. The role of mitochondria in NLRP3 inflammasome activation.
Liu Q; Zhang D; Hu D; Zhou X; Zhou Y
Mol Immunol; 2018 Nov; 103():115-124. PubMed ID: 30248487
[TBL] [Abstract][Full Text] [Related]
13. The intersection of cell death and inflammasome activation.
Vince JE; Silke J
Cell Mol Life Sci; 2016 Jun; 73(11-12):2349-67. PubMed ID: 27066895
[TBL] [Abstract][Full Text] [Related]
14. Targeted P2X7/NLRP3 signaling pathway against inflammation, apoptosis, and pyroptosis of retinal endothelial cells in diabetic retinopathy.
Kong H; Zhao H; Chen T; Song Y; Cui Y
Cell Death Dis; 2022 Apr; 13(4):336. PubMed ID: 35410316
[TBL] [Abstract][Full Text] [Related]
15. Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy.
Louie HH; Shome A; Kuo CY; Rupenthal ID; Green CR; Mugisho OO
Exp Eye Res; 2021 Jan; 202():108384. PubMed ID: 33285185
[TBL] [Abstract][Full Text] [Related]
16. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy.
Loukovaara S; Piippo N; Kinnunen K; Hytti M; Kaarniranta K; Kauppinen A
Acta Ophthalmol; 2017 Dec; 95(8):803-808. PubMed ID: 28271611
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model.
Luo B; Li B; Wang W; Liu X; Xia Y; Zhang C; Zhang M; Zhang Y; An F
PLoS One; 2014; 9(8):e104771. PubMed ID: 25136835
[TBL] [Abstract][Full Text] [Related]
18. UFL1 modulates NLRP3 inflammasome activation and protects against pyroptosis in LPS-stimulated bovine mammary epithelial cells.
Li C; Wang X; Kuang M; Li L; Wang Y; Yang F; Wang G
Mol Immunol; 2019 Aug; 112():1-9. PubMed ID: 31078114
[TBL] [Abstract][Full Text] [Related]
19. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.
Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J
Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825
[TBL] [Abstract][Full Text] [Related]
20. Cytokine Secretion and Pyroptosis of Thyroid Follicular Cells Mediated by Enhanced NLRP3, NLRP1, NLRC4, and AIM2 Inflammasomes Are Associated With Autoimmune Thyroiditis.
Guo Q; Wu Y; Hou Y; Liu Y; Liu T; Zhang H; Fan C; Guan H; Li Y; Shan Z; Teng W
Front Immunol; 2018; 9():1197. PubMed ID: 29915579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
